DK138492B - Fremgangsmåde til fremstilling af morphinanderivater. - Google Patents

Fremgangsmåde til fremstilling af morphinanderivater.

Info

Publication number
DK138492B
DK138492B DK259373AA DK259373A DK138492B DK 138492 B DK138492 B DK 138492B DK 259373A A DK259373A A DK 259373AA DK 259373 A DK259373 A DK 259373A DK 138492 B DK138492 B DK 138492B
Authority
DK
Denmark
Prior art keywords
preparation
morphinan derivatives
morphinan
derivatives
Prior art date
Application number
DK259373AA
Other languages
Danish (da)
English (en)
Other versions
DK138492C (nl
Inventor
Ivo Monkovic
Terry Thomas Conway
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK138492B publication Critical patent/DK138492B/da
Application granted granted Critical
Publication of DK138492C publication Critical patent/DK138492C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK259373AA 1972-05-10 1973-05-10 Fremgangsmåde til fremstilling af morphinanderivater. DK138492B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25187972A 1972-05-10 1972-05-10

Publications (2)

Publication Number Publication Date
DK138492B true DK138492B (da) 1978-09-18
DK138492C DK138492C (nl) 1979-02-19

Family

ID=22953785

Family Applications (1)

Application Number Title Priority Date Filing Date
DK259373AA DK138492B (da) 1972-05-10 1973-05-10 Fremgangsmåde til fremstilling af morphinanderivater.

Country Status (13)

Country Link
US (1) US3775414A (nl)
JP (1) JPS535672B2 (nl)
CA (1) CA989827A (nl)
CH (1) CH590238A5 (nl)
CS (3) CS178425B2 (nl)
DD (1) DD106841A5 (nl)
DK (1) DK138492B (nl)
HU (2) HU168597B (nl)
IL (1) IL42219A (nl)
NL (1) NL155256B (nl)
OA (1) OA04406A (nl)
SE (2) SE403106B (nl)
YU (1) YU36505B (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910920A (en) * 1973-11-07 1975-10-07 Bristol Myers Co 3,14,17-Substituted-6,7-tetramethylenemorphinans
US3980641A (en) * 1975-07-31 1976-09-14 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinans
US4017497A (en) * 1975-11-18 1977-04-12 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
JPS52136176A (en) * 1976-03-23 1977-11-14 Bristol Myers Co Method of improving 144hydroxymorphinan derivatives
US4139534A (en) * 1977-02-17 1979-02-13 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4052389A (en) * 1976-03-23 1977-10-04 Bristol-Myers Company Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one
US4115389A (en) * 1977-05-02 1978-09-19 Bristol-Myers Company Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline
NO793297L (no) * 1978-10-19 1980-04-22 Mallinckrodt Inc Fremgangsmaate til fremstilling av oksymorfon
US4272540A (en) * 1979-04-24 1981-06-09 Sisa, Incorporated 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them
NO802139L (no) * 1979-08-09 1981-02-10 Mallinckrodt Inc Utgangsforbindelser for fremstilling av morfinderivater, samt fremgangsmaate til fremstilling av utgangsforbindelsene
US5109136A (en) * 1990-08-09 1992-04-28 Warner-Lambert Company Tetracyclic amines useful as cerebrovascular agents
KR102102513B1 (ko) 2014-10-14 2020-04-20 히사미쓰 세이야꾸 가부시키가이샤 첩부제
WO2017168444A1 (en) * 2016-03-29 2017-10-05 Hikal Limited An improved process for the preparation of butorphanol tartrate
JP6865235B2 (ja) 2016-12-28 2021-04-28 久光製薬株式会社 ブトルファノール含有貼付剤
JP6773897B2 (ja) 2017-04-25 2020-10-21 久光製薬株式会社 貼付剤
US11202764B2 (en) 2017-04-25 2021-12-21 Hisamitsu Pharmaceutical Co., Inc. Patch
CN112592342B (zh) * 2021-01-15 2022-02-22 福安药业集团重庆礼邦药物开发有限公司 一种布托啡诺脱环丁基杂质化合物的制备方法

Also Published As

Publication number Publication date
CS178425B2 (nl) 1977-09-15
US3775414A (en) 1973-11-27
SE7604162L (sv) 1976-04-08
CA989827A (en) 1976-05-25
DD106841A5 (nl) 1974-07-05
HU169023B (nl) 1976-09-28
DK138492C (nl) 1979-02-19
OA04406A (fr) 1980-02-29
CH590238A5 (nl) 1977-07-29
NL155256B (nl) 1977-12-15
CS178446B2 (nl) 1977-09-15
JPS535672B2 (nl) 1978-03-01
YU119773A (en) 1982-02-25
HU168597B (nl) 1976-06-28
SE403106B (sv) 1978-07-31
IL42219A0 (en) 1973-07-30
IL42219A (en) 1977-06-30
JPS4961169A (nl) 1974-06-13
SE411042B (sv) 1979-11-26
CS178447B2 (nl) 1977-09-15
NL7306344A (nl) 1973-11-13
YU36505B (en) 1984-02-29

Similar Documents

Publication Publication Date Title
DK137329B (da) Analogifremgangsmåde til fremstilling af 2-karbalkoksyaminobenzimidazolderivater.
DK134607B (da) Fremgangsmåde til fremstilling af rapamycin.
DK140340B (da) Analogifremgangsmåde til fremstilling af benzoxazolderivater.
DK138492B (da) Fremgangsmåde til fremstilling af morphinanderivater.
DK136312B (da) Analogifremgangsmåde til fremstilling af substituerede piperidinoalkanonoximderivater.
DK134490B (da) Analogifremgangsmåde til fremstilling af 2,6-diaminonebularin-derivater.
DK135991B (da) Analogifremgangsmåde til fremstilling af 2-oxazolinderivater.
DK136360B (da) Analogifremgangsmåde til fremstilling af isoindolinderivater.
DK137955B (da) Analogifremgangsmåde til fremstilling af morphinan-derivater.
DK134604B (da) Fremgangsmåde til fremstilling af indenyl-3-acetoglucuronider.
DK138796B (da) Analogifremgangsmåde til fremstilling af 2-carboxypyrazin-4-oxidderivater.
DK140668B (da) Analogifremgangsmåde til fremstilling af kondenserede pyriminderivater.
DK138230B (da) Analogifremgangsmåde til fremstilling af vincanolsalte.
DK131864B (da) Fremgangsmåde til fremstilling af pregnan-21-syrederivater.
FI52735C (fi) Menetelmä uusien pregnadieeni-21-happojohdannaisten valmistamiseksi.
DK135122B (da) Analogifremgangsmåde til fremstilling af 4-aryl-5-aminoalkyl-4-oxazolin-2-onderivater.
DK136361B (da) Fremgangsmåde til fremstilling af quinolin-derivater.
DK132430B (da) Fremgangsmåde til fremstilling af quinazolinonderivater.
DK131575B (da) Analogifremgangsmåde til fremstilling af 2beta-hydroxy-3alfa-aminosteroider.
DK138645B (da) Analogifremgangsmåde til fremstilling af sulfamoylfenyl-imidazolidiner.
DK133667B (da) Fremgangsmåde til fremstilling af 5-cyklohexyl-6-halogenindan-1-karboxylsyrederivater.
DK135166B (da) Analogifremgangsmåde til fremstilling af 2-methyl-5-nitro-imidazoler.
DK129657B (da) Analogifremgangsmåde til fremstilling af 3-methylpyrazol-5-carboxamider.
DK134183B (da) Fremgangsmåde til fremstilling af cellulose-enzymkomplekser.
DK139677B (da) Fremgangsmåde til fremstilling af 7-benzoylindolin-2-oner.